Collaborate Disseminate
Research into clinical uses for psychedelics has proliferated in recent years, but despite the constant stream of “psychedelic renaissance” news, the vast majority of studies remain in early, preliminary stages. Apart from one notable modality (MDMA-as… Continue reading The world’s first Phase 3 psilocybin clinical trial is about to commence
Research into clinical uses for psychedelics has proliferated in recent years, but despite the constant stream of “psychedelic renaissance” news, the vast majority of studies remain in early, preliminary stages. Apart from one notable modality (MDMA-as… Continue reading The world’s first Phase 3 psilocybin clinical trial is about to commence
Research into clinical uses for psychedelics has proliferated in recent years, but despite the constant stream of “psychedelic renaissance” news, the vast majority of studies remain in early, preliminary stages. Apart from one notable modality (MDMA-as… Continue reading The world’s first Phase 3 psilocybin clinical trial is about to commence
The US Food and Drug Administration (FDA) has approved a new anti-wrinkle treatment called Daxxify. Similar to the popular Botox, Daxxify freezes wrinkles by paralyzing muscles but lasts at least twice as long as current treatments, with single injecti… Continue reading New long-lasting anti-wrinkle Botox rival approved by FDA
The US Food and Drug Administration (FDA) has authorized new mRNA vaccine booster shots targeting the BA.4 and BA.5 Omicron variant of SARS-CoV-2. The authorization marks the first updated COVID-19 vaccines to be made available in the United States sin… Continue reading Omicron COVID vaccine booster authorized in US, roll-out begins in days
The US Food and Drug Administration (FDA) has approved the first ever cell-based gene therapy, a one-off treatment for patients with a rare genetic blood disease. The single treatment will cost US$2.8 million, making it the most expensive medicine in h… Continue reading New $2.8-million gene therapy becomes most expensive medicine in history
The US FDA has issued a final rule that establishes a new category of over-the-counter (OTC) hearing aids. The move comes as part of a push by the US government to make healthcare more affordable, allowing millions of people to buy low-cost hearing aid… Continue reading US FDA ruling allows low-cost hearing aids to be sold over-the-counter
After months of delays the US Food and Drug Administration (FDA) has finally issued an emergency use authorization (EUA) for the Novavax COVID-19 vaccine. Once doses are available this will be the first protein-based COVID vaccine authorized in the Uni… Continue reading FDA finally authorizes Novavax COVID-19 vaccine in US
More than 18 months ago a global COVID-19 vaccine roll-out commenced, beginning the biggest international immunization campaign seen in decades. Since then, the virus that causes COVID-19 has mutated significantly and health authorities have been discu… Continue reading FDA and WHO disagree on COVID-19 vaccine booster variant advice
Biotech company Novavax has revealed its COVID-19 vaccine can generate effective immune responses against all circulating Omicron variants. The unexpected data was delivered to an advisory panel convened by the US Food and Drug Administration (FDA) to … Continue reading Novavax COVID vaccine surprisingly effective against all Omicron variants